Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing

被引:0
|
作者
Sowmya, S. V. [1 ]
Augustine, Dominic [1 ]
Mushtaq, Shazia [2 ]
Baeshen, Hosam Ali [3 ]
Ashi, Heba [4 ]
Hassan, Reem Nabil [5 ]
Alshahrani, Mohammed [6 ]
Patil, Shankargouda [7 ]
机构
[1] MS Ramaiah Univ Appl Sci, Fac Dent Sci, Dept Oral Pathol & Microbiol, Bengaluru, Karnataka, India
[2] King Saud Univ, Coll Appl Med Sci, Dent Hlth Dept, Riyadh, Saudi Arabia
[3] King Abdulaziz Univ, Fac Dent, Dept Orthodont, Jeddah, Saudi Arabia
[4] King Abdulaziz Univ, Fac Dent, Dept Dent Publ Hlth, Jeddah, Saudi Arabia
[5] King Abdulaziz Univ, Fac Sci, Biol Sci Dept Genome, Jeddah, Saudi Arabia
[6] King Abdulaziz Univ, Fac Dent, Endodont Dept, Jeddah, Saudi Arabia
[7] Roseman Univ Hlth Sci, Coll Dent Med, South Jordan, UT USA
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
CRISPR-Cas9; gene editing; oral cancer; CRISPR-screens; genetic editing; POOLED IN-VITRO; CLINICAL-TRIAL; 1ST TRIAL; CRISPR/CAS9; CELLS; DELIVERY; PROGRESS; THERAPY; SYSTEM; TOOL;
D O I
10.3389/fonc.2024.1383062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review presents an in-depth analysis of the immense potential of CRISPR-Cas9 technology in revolutionizing oral cancer research. It underscores the inherent limitations of conventional treatments while emphasizing the pressing need for groundbreaking approaches. The unparalleled capability of CRISPR-Cas9 to precisely target and modify specific genes involved in cancer progression heralds a new era in therapeutic intervention. Employing genome-wide CRISPR screens, vulnerabilities in oral cancer cells can be identified, thereby unravelling promising targets for therapeutic interventions. In the realm of oral cancer, the disruptive power of CRISPR-Cas9 manifests through its capacity to perturb genes that are intricately associated with drug resistance, consequently augmenting the efficacy of chemotherapy. To address the challenges that arise, this review diligently examines pertinent issues such as off-target effects, efficient delivery mechanisms, and the ethical considerations surrounding germline editing. Through precise gene editing, facilitated by CRISPR/Cas9, it becomes possible to overcome drug resistance by rectifying mutations, thereby enhancing the efficacy of personalized treatment strategies. This review delves into the prospects of CRISPR-Cas9, illuminating its potential applications in the domains of medicine, agriculture, and biotechnology. It is paramount to emphasize the necessity of ongoing research endeavors and the imperative to develop targeted therapies tailored specifically for oral cancer. By embracing this comprehensive overview, we can pave the way for ground-breaking treatments that instill renewed hope for enhanced outcomes in individuals afflicted by oral cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] CRISPR-cas9 Gene Editing for Cystic Fibrosis
    Xia, Emily
    MOLECULAR THERAPY, 2019, 27 (04) : 196 - 196
  • [42] CRISPR-Cas9 gene editing and human diseases
    Jinka, Chaitra
    Sainath, Chithirala
    Babu, Shyamaladevi
    Chakravarthi, Chennupati Ashok
    Prasanna, Muppidi Lakshmi
    Krishnan, Madhan
    Sekar, Gayathri
    Chinnaiyan, Mayilvanan
    Kumari, Andugula Swapna
    BIOINFORMATION, 2022, 18 (11) : 1081 - 1086
  • [43] Photoactivatable CRISPR-Cas9 for optogenetic genome editing
    Yuta Nihongaki
    Fuun Kawano
    Takahiro Nakajima
    Moritoshi Sato
    Nature Biotechnology, 2015, 33 : 755 - 760
  • [44] Inducible in vivo genome editing with CRISPR-Cas9
    Lukas E Dow
    Jonathan Fisher
    Kevin P O'Rourke
    Ashlesha Muley
    Edward R Kastenhuber
    Geulah Livshits
    Darjus F Tschaharganeh
    Nicholas D Socci
    Scott W Lowe
    Nature Biotechnology, 2015, 33 : 390 - 394
  • [45] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
    不详
    LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
  • [46] Inducible in vivo genome editing with CRISPR-Cas9
    Dow, Lukas E.
    Fisher, Jonathan
    O'Rourke, Kevin P.
    Muley, Ashlesha
    Kastenhuber, Edward R.
    Livshits, Geulah
    Tschaharganeh, Darjus F.
    Socci, Nicholas D.
    Lowe, Scott W.
    NATURE BIOTECHNOLOGY, 2015, 33 (04) : 390 - U98
  • [47] CRISPR-Cas9 Based Bacteriophage Genome Editing
    Zhang, Xueli
    Zhang, Chaohui
    Liang, Caijiao
    Li, Bizhou
    Meng, Fanmei
    Ai, Yuncan
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [48] Development and application of CRISPR-Cas9 for genome editing
    Zhang, Feng
    TRANSGENIC RESEARCH, 2014, 23 (05) : 842 - 842
  • [49] The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy
    Bharucha, Nike
    Arias, Ariel
    Karakikes, Ioannis
    CURRENT OPINION IN CARDIOLOGY, 2022, 37 (05) : 413 - 418
  • [50] Specificity of CRISPR-Cas9 Editing in Exagamglogene Autotemcel
    Yen, Angela
    Zappala, Zachary
    Fine, Rebecca S.
    Majarian, Timothy D.
    Sripakdeevong, Parin
    Altshuler, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (18): : 1723 - 1725